Top news

View all

22 May 2023

Global vaccine alliance outlines path to sustainable cholera vaccine supply

Global oral cholera vaccine (OCV) supply could enable large-scale preventive vaccination by 2026 – but urgent action is needed to achieve this goal.

15 May 2023

Amidst crises, Malawi showcases resilience with major vaccination push

Malawi becomes the third African country to introduce typhoid conjugate vaccine (TCV) into routine immunisation as Ministry of Health and partners collaborate to protect children across the country from typhoid fever.

15 May 2023

Signing of a new agreement to drive vaccine impact in Africa

The African Union Commission (AUC) and Gavi, the Vaccine Alliance (Gavi), signed a Memorandum of Understanding (MoU) to increase access and accelerate the uptake of life-saving vaccines.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published once a month.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

2 June 2023

“Faces are like water in my head”: What happens when COVID-19 affects the brain?

Scientists are increasingly recognising that COVID-19 can have lasting and debilitating neurological symptoms, as well as causing structural changes to the brain.

2 June 2023

Lagos steps up search for uncounted, untreated TB patients

Finding “missing cases” of tuberculosis, still one of the world’s greatest killers, is key to interrupting transmission and halting the disease. Lagos State in Nigeria is rolling out new strategies.

2 June 2023

Child immunisations continue amidst conflict

“We thought that the conflict will stop the vaccinations, but thankfully it is going on.”

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter